Discover 2,200 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,200
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Stanford CA, San Francisco CA, Santa Monica CA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: San Francisco CA, Stockton CA, Santa Rosa CA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Location: Palo Alto CA, Oakland CA, Los Angeles CA, Denver CO,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 17
Code: NCT06651580
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Location: Palo Alto CA, Sacramento CA, Los Angeles CA, Irvine CA,
Sponsor: Aptose Biosciences Inc.
Sex: All
Age: 18+
Code: NCT03850574
Phase1, Phase2, Recruiting
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Palo Alto CA, San Antonio TX, Toronto, Fairfax VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06532565
Phase1, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Stanford CA, Sacramento CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Palo Alto CA, Santa Monica CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase1, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Palo Alto CA, Duarte CA, Las Vegas NV, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase2, Phase3, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: Palo Alto CA, Duarte CA, Dallas TX, Pittsburgh PA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Palo Alto CA, Milwaukee WI, Chicago IL, Atlanta GA,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase1, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Palo Alto CA, San Francisco CA, Portland OR, Seattle WA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for
Relapsed and/or Refractory B-cell Lymphoma
Location: Stanford CA, Duarte CA, Gilbert AZ, Austin TX,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT04989803
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Stanford CA, San Francisco CA, Los Angeles CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Palo Alto CA, Irvine CA, Phoenix AZ, Aurora CO,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)